English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17775/20116 (88%)
Visitors : 9404823      Online Users : 338
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/27791

    標題: Cardiac Peroxisome Proliferator-Activated Receptor delta (PPAR delta) as a New Target for Increased Contractility without Altering Heart Rate
    作者: Chen, Zhih-Cherng
    Lee, Kung Shing
    Chen, Li-Jen
    Wang, Lin-Yu
    Niu, Ho-Shan
    Cheng, Juei-Tang
    貢獻者: 藥學系
    關鍵字: Troponin-I Phosphorylation
    Fatty-Acid Oxidation
    Cardiotonic Activity
    Regulatory Function
    Septic Shock
    日期: 2013-05
    上傳時間: 2014-05-26 10:43:49 (UTC+8)
    出版者: Public Library Science
    摘要: Background and Aims: Agents having a positive inotropic effect on the heart are widely used for the treatment of heart failure. However, these agents have the side effect of altering heart rate. It has been established that peroxisome proliferator-activated receptor delta (PPAR delta) is mediated in cardiac contraction, however the effect on heart rate is unknown. Thus, we used an agonist of PPAR delta, GW0742, to investigate this issue in the present study.Methods and Results: We used isolated hearts in Langendorff apparatus and hemodynamic analysis in catheterized rats to measure the actions of GW0742 extra-vivo and in vivo. In diabetic rats with heart failure, GW0742 at a dose sufficient to activate PPAR delta reversed cardiac contraction without changes in heart rate. In normal rats, PPAR delta enhanced cardiac contractility and hemodynamic dP/dt(max) significantly more than dobutamine. Both actions were diminished by GSK0660 at a dose enough to block PPAR delta. However, GW0742 at the same dose failed to modify heart rate, although it did produce a mild increase in blood pressure. Detection of intracellular calcium level and Western blotting analysis showed that the intracellular calcium concentration and troponin I phosphorylation were both enhanced by GW0742.Conclusion: Activation of PPAR delta by GW0742 increases cardiac contractility but not heart rate. Thus, PPAR delta may be a suitable target for the development of inotropic agents to treat heart failure without changing heart rate.
    關聯: Plos One, v.8 n.5 e64229
    Appears in Collections:[藥學系(所)] 期刊論文

    Files in This Item:

    File Description SizeFormat

    All items in CNU IR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback